IL-6 has been reported to be a proliferative factor for diverse tumor types in vivo[28-30], and elevated serum levels of IL-6 have been associated with key features of malignancy, cancer progression and a poor clinical outcome in different types of cancers [31-37]. This evidence concerns the gene IL6 and cancer.